| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human PFKFB4 recombinant protein (Position: M1-K298) was used as the immunogen for the PFKFB4 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
PFKFB4 Antibody / PFK/FBPase 4 is an antibody targeting PFKFB4. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, ELISA.
Key elements and design rationale
- Target: PFKFB4.
- Immunogen: E.coli-derived human PFKFB4 recombinant protein (Position: M1-K298) was used as the immunogen for the PFKFB4 antibody..
- Species reactivity: Human.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
PFKFB4 antibody detects 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4, encoded by the PFKFB4 gene on chromosome 3p21.1. PFKFB4 antibody is widely used in studies of glycolysis, metabolic regulation, and cancer biology.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
